SNI Blog

SNI Blog

Multimodal Treatment of Spinal Tumors symposium

Karen Pabillon
Join us next week!
Multimodal Treatment of Spinal Tumors symposium
Friday, February 25, 2011

Course Chair: Rod J. Oskouian, Jr., M.D, Neurosurgery, Spine Surgery, Swedish Neuroscience Institute.

Today, health-care providers who treat patients with spinal tumors are able to offer a myriad of treatment options that were essentially non-existent in the recent past. Internationally renowned speaker, inventor, entrepreneur and neurosurgeon, John R. Alder, M.D., will present the keynote presentation at this year's symposium and initiate our discussion of the technical and therapeutic options available for spinal tumor patients.

For full course information and to register: http//www.swedish.org/spinaltumors2011

Pediatric Neuroscience Center receives “Tuberous Sclerosis Complex (TSC) Clinic” Designation

Karen Pabillon

The Tuberous Sclerosis Alliance announced today that it has designated the Swedish Pediatric Neuroscience Center (SPNC) at SNI as a TSC Clinic. Marcio Sotero, MD, medical director of SPNC, is the director of the new center. This designation is an important step forward in the regional delivery of care to patients with tuberous sclerosis, as the TSC Clinics closest to Seattle are located at the Barrow Neurological Institute in Phoenix and Children’s Hospital in Oakland, CA.

TSC is a genetic disorder that causes tumors to form in many different organs, primarily in the brain, eyes, heart, kidney, skin and lungs. Seizures are a very common manifestation, and some people with TSC experience developmental delay, mental retardation and autism.

SNI Grand Round Series 2011 - Epilepsy Genetics

Karen Pabillon
Thursday, February 3, 2011
7:30am - 8:30am
Swedish Education Conference Center, Room B

 

Marcio Sotero de Menezes, MD, Pediatric Epilepsy, Pediatric Neurology, Swedish Neuroscience Institute

 

 

 

Objectives:

At the conclusion of this session, attendees will have an increased ability to:

  • Identify genetic epilepsy syndromes
  • Explain treatment of genetic epilepsy syndromes

SNI Grand Round Series is every 1st and 3rd Thursday of each month.

Winter Issue of BrainWaves Now Available

Karen Pabillon

 

 

 

 

 

 

The Winter 2010 edition of BrainWaves is now available online.

BrainWaves is the newsletter of the Swedish Neuroscience Institute. Published quarterly, BrainWaves provides information about neurological conditions treated at the Institute, and also profiles the programs, services, and new initiatives of the institute and its staff.

 

Also check out our past editions of the BrainWaves newsletter.

SNI Grand Rounds Series 2011 - Opportunities with Implantable Hearing Technologies

Karen Pabillon
Thursday, January 6, 2011
7:30am - 8:30am
Swedish Education and Conference Center, Room B
Douglas Backous, Neurotology, Otology, Swedish Neuroscience Institute

Objectives: At the conclusion of this session, attendees will have an increased ability to:

  • Discuss the options for hearing restoration using osteointegrated implants and cochlear implants
  • Describe the role of auditory brainstem implants
  • Outline the indications for cochlear implants and auditory brainstem implants (ABI)

SNI Grand Round Series is every 1st and 3rd Thursday of each month.

Detection of Cerebral Microemboli by Transcranial Doppler

John W Henson IV

John W Henson IV
Director, Neurology

FROM BRAINWAVES: Since its introduction in 1982, transcranial doppler ultrasound (TCD) has evolved into a portable, multimodality, noninvasive method for real-time imaging of intracranial vasculature. The detection of cerebral microemboli is among the more remarkable capabilities of TCD. Emboli create countable signals in the ultrasound display due to the higher reflection of sound waves compared to the blood cells. Experimental models have shown a high sensitivity and specificity for detection of a variety of substrates, including thrombotic, platelet and atheromatous emboli.

Microembolic signals (MES) within the intracranial vasculature are most frequently identified in patients with large-vessel atherosclerotic disease, such as carotid stenosis. They have also been reported in intracranial arterial stenosis, arterial dissection, cardiac disease and atheroaortic plaque. Additionally, they have been seen in arteries distal to coiled aneurysms.

There is strong evidence that MES detection predicts future ipsilateral stroke risk in patients with symptomatic carotid stenosis (Markus HS, et al.; King A, et al.). A recent study of patients with asymptomatic carotid stenosis demonstrated that MES predicted subsequent ipsilateral stroke and TIA, and also ipsilateral stroke alone, and that it is helpful in selecting patients who will benefit from carotid endarterectomy.

Swedish Expands Radiosurgery Services

Karen Pabillon

There was cause for celebration in the Swedish Radiosurgery Center on Thursday, Dec. 16, as neurosurgeon Ronald Young, M.D. (left), medical director of the Gamma Knife® program, and radiation oncologist Bob Meier, M.D. (below), medical director of the CyberKnife program, treated the center’s first two Gamma Knifepatients. The center, formerly known as the Seattle CyberKnife Center, supports both the Swedish Cancer Institute and the Swedish Neuroscience Institute.

The center has offered CyberKnife services since 2006. This year Swedish installed an Elekta Leksell Perfexion Gamma Knife®, making it one of the most advanced stereotactic radiosurgery centers in the country. CyberKnife can be used to treat cancerous and noncancerous tumors in all areas of the body.

At Swedish, Gamma Knife will be used to treat cancer of the brain and some neurological conditions, such as essential tremor, trigeminal neuralgia and arteriovenous malformations. Providing Swedish neurosurgeons and radiation oncologists access to both of these advanced technologies gives them greater flexibility in selecting the best radiation therapy for their patients. For more information, go to www.swedish.org/radiosurgery or call 206-320-7130.

Results 36-42 of 61

Top Authors

Karen Pabillon
John W Henson IV

John W Henson IV
Director, Neurology

Erin Kieper

Erin Kieper
Program Development Manager, Swedish Radiosurgery Center

David W. Newell, MD